Endo Health Solutions Inc (NASDAQ:ENDP)
| 33.69 Real-Time Quote |  -0.35 / -1.03%Today’s Change | 25.01 Today|||52-Week Range 38.32 | +28.44% Year-to-Date |
Latest ENDP News | Press Releases
| Setback for Endo Health on Opana ER - Analyst Blog May 13 / Zacks.com | Company News for May 8, 2013 - Corporate Summary May 08 / Zacks.com |
| Earnings Beat at Endo Health, Sales Slip - Analyst Blog May 08 / Zacks.com |
Today’s Trading
| Previous close | 34.04 |
| Today’s open | 34.02 |
| Day’s range | 33.80 - 34.60 |
| Volume | 1,245,574 |
| Average volume (3 months) | 2,645,235 |
| Market cap | $3.8B |
| Dividend yield | -- |
Data as of 2:19pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -512.90% |
| Earnings growth (this year) | -15.26% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +10.89% |
| P/E ratio | NM |
| Price/Sales | 1.00 |
| Price/Book | 3.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| THRXTheravance Inc | -1.39 | -3.70% |
| SLXPSalix Pharmaceutical... | -0.37 | -0.62% |
| MDVNMedivation Inc | +0.34 | +0.70% |
| JAZZJazz Pharmaceuticals... | +1.51 | +2.52% |
Data as of 2:22pm ET, 05/22/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $1.16 |
| Annual revenue (last year) | $3.0B |
| Annual profit (last year) | -$740.3M |
| Net profit margin | -24.45% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Rajiv de Silva, MBA |
Chief Operating Officer Julie H. McHugh, MBA |
Corporate headquarters Malvern, Pennsylvania |
Forecasts
